mRNA-2808

A Phase 1/2, Open-label, Multicenter Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

More Information

Trial Status
Not yet accepting
Trial Phase
Phase 1/2
Enrollment
166 patients (estimated)
Sponsors
ModernaTX, Inc.
Trial Type
Treatment
Last Update
4 days ago
SparkCures ID
2157
NCT Identifier
NCT07116616

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.